Vascular risk factor awareness before and pharmacological treatment before and 
after stroke and TIA

Nolte, C. H.; Jungehülsing, Gerhard J.; Rossnagel, K.; Roll, S.; Haeusler, K. G.; Reich, A.; Willich, S. N.; Villringer, Arno; Müller-Nordhorn, J.

doi:10.1111/j.1468-1331.2009.02562.x

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Vascular risk factor awareness before and pharmacological treatment before and after stroke and TIA

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Nolte, C. H., Jungehülsing, G. J., Rossnagel, K., Roll, S., Haeusler, K. G., Reich, A., Willich, S. N., Villringer, A., & Müller-Nordhorn, J. (2009). Vascular risk factor awareness before and pharmacological treatment before and after stroke and TIA. European Journal of Neurology, 16(6), 678-683. doi:10.1111/j.1468-1331.2009.02562.x.

引用: https://hdl.handle.net/11858/00-001M-0000-0010-E785-5

要旨

BACKGROUND AND PURPOSE: Educating the public to screen for vascular risk factors and have them treated is a major public health issue. We assessed the vascular risk factor awareness and frequency of treatment in a cohort of patients with cerebral ischaemia. METHODS: Data on awareness and pharmacological treatment of vascular risk factors before hospital admission of patients with confirmed ischaemic stroke/transient ischaemic attack (TIA) were analyzed. A follow-up questionnaire assessed the frequency of treatment 1 year after discharge and assessed non-adherence to antithrombotic medication. RESULTS: At time of stroke/TIA, individual awareness regarding existing hypertension, diabetes, hyperlipidemia and atrial fibrillation (AF) was 83%, 87%, 73% and 69% respectively (n = 558). Pharmacological treatment for hypertension, diabetes, hyperlipidemia and AF was being administered in 80%, 77%, 37% and 62% of patients aware of their conditions. The follow-up was completed by 383 patients (80% recall rate): of the patients with hypertension, diabetes, hyperlipidemia and AF, 89%, 78%, 45% and 86% were receiving risk factor targeted medication. This represents a significant increase concerning AF and hyperlipidemia. Non-adherence to recommended antithrombotics (15%) was higher in patients who had had a TIA. CONCLUSIONS: All risk factors leave room for improvement in screening and treatment efforts. Adherence to treatment is higher for hypertension and diabetes than for hyperlipidemia. Education efforts should bear in mind less well recognized risk factors.